Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

PDF Text

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Name of Patient : Mr.

PARMINDER SINGH Test Request ID : 20962309090001


Age/Gender : 32 Yrs/Male Specimen Drawn ON : 09-Sep-2023 04:49PM
Collected AT : PUBLIC CLINICAL LABORATORY Specimen Received ON : 09-Sep-2023 04:49PM
Referred BY : Dr. PUBLIC LAB Report DATE : 09-Sep-2023 06:13PM
Sample Type : EDTA Blood - A5012026
Ref Customer :

HAEMATOLOGY
Test Name Result Biological Reference Method
Range
HbA1c (ngsp) 10.7 Non diabetic adults >=18 HPLC
years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
%
HbA1c (IFCC) 93.2 mmol/mol HPLC
Estimated Average Glucose 260.39 mg/dl
Please correlate clinically.
Interpretation:
As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5Note:

1, Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still
have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.

2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0
% may not be appropriate.

Comment: HBA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term
glycemic control as compared to blood and urinary glucose determinations.

QR CODE
NABL CERTIFICATE

Page 1 of 2
Disclaimer:-This report is not for medico-legal purpose. For test performed on specimens received or collected from non-CRL locations, it is presumed that the specimen belongs to the patient named or identified as labeled on the container/test request and such verification has been
carried
out at the point generation of the said specimen by the sender. CRL will be responsible Only for the analytical part of test carried out. All other responsibility will be of referring Laboratory.sample processed and reported at CRL DIAGNOSTICS PVT. LTD , Delhi.
Name of Patient : Mr. PARMINDER SINGH Test Request ID : 20962309090001
Age/Gender : 32 Yrs/Male Specimen Drawn ON : 09-Sep-2023 04:49PM
Collected AT : PUBLIC CLINICAL LABORATORY Specimen Received ON : 09-Sep-2023 04:49PM
Referred BY : Dr. PUBLIC LAB Report DATE : 09-Sep-2023 06:13PM
Sample Type : EDTA Blood - A5012026
Ref Customer :

Nabl Scope.
*** End Of Report ***

QR CODE
NABL CERTIFICATE

Page 2 of 2
Disclaimer:-This report is not for medico-legal purpose. For test performed on specimens received or collected from non-CRL locations, it is presumed that the specimen belongs to the patient named or identified as labeled on the container/test request and such verification has been
carried
out at the point generation of the said specimen by the sender. CRL will be responsible Only for the analytical part of test carried out. All other responsibility will be of referring Laboratory.sample processed and reported at CRL DIAGNOSTICS PVT. LTD , Delhi.

You might also like